...
首页> 外文期刊>Journal of clinical anesthesia >High incidence of intravenous thrombi after short-term central venous catheterization of the internal jugular vein.
【24h】

High incidence of intravenous thrombi after short-term central venous catheterization of the internal jugular vein.

机译:颈内静脉短期中心静脉置管后静脉血栓形成高发。

获取原文
获取原文并翻译 | 示例

摘要

STUDY OBJECTIVE: To assess incidence and characteristics of intravenous (i.v.) thrombi associated with short-term central venous catheterization through the internal jugular vein. DESIGN: Prospective clinical study. SETTING: University hospital. PATIENTS: 81 patients undergoing cardiac surgery. INTERVENTIONS: A triple-lumen central venous catheter was inserted into the right internal jugular vein immediately before surgery and removed 3 to 4 days later. Heparin at an i.v. dose of 15,000 IU/24 hours was started 6 hours after surgery and continued until the first postoperative morning, followed by subcutaneous low molecular weight heparin 5,000 IU/day in combination with oral aspirin 100 mg/day. MEASUREMENTS AND MAIN RESULTS: Anatomy of the internal jugular vein and i.v. blood flow were studied using two-dimensional and color Doppler ultrasonography before insertion of the catheter and after its removal. Thrombi were found in 45 patients (56%). Twenty-five of these thrombi (56%) had the shape of a sleeve, and 20 thrombi (44%) were compact. Length of the thrombi was 1.4 +/- 0.8 cm (mean +/- SD). Half of the thrombi floated with venous blood flow and half were stable. Neither impaired venous blood flow nor clinical signs of embolism or sepsis was found. Follow-up studies in eight patients revealed that the thrombi had not disappeared 5 days after removal of the catheter but had become smaller. CONCLUSION: The incidence of i.v. thrombi associated with short-term catheterization of the internal jugular vein was high despite prophylactic anticoagulation. This finding reaffirms the importance of removing central venous catheters as soon as clinically possible. Additional studies using specific outcome tests are needed to thoroughly assess the clinical importance of this finding.
机译:研究目的:评估与短期内通过颈内静脉中心静脉置管相关的静脉(i.v.)血栓的发生率和特征。设计:前瞻性临床研究。地点:大学医院。患者:81例接受心脏手术的患者。干预措施:术前立即将三腔中央静脉导管插入右颈内静脉,并在3至4天后取出。静脉注射肝素术后6小时开始剂量为15,000 IU / 24小时,一直持续到术后第一个早晨,然后皮下注射低分子量肝素5,000 IU /天,联合口服阿司匹林100 mg /天。测量和主要结果:颈内静脉和静脉的解剖。在插入导管之前和取出导管后,使用二维和彩色多普勒超声检查血流。在45例患者中发现了血栓(56%)。这些血栓中有25个(56%)具有袖子形状,而紧凑的有20个血栓(44%)。血栓的长度是1.4 +/- 0.8cm(平均+/- SD)。一半的血栓随静脉血流漂浮,另一半则稳定。既未发现静脉血流受损,也未发现栓塞或败血症的临床体征。对八名患者的随访研究表明,在拔除导管5天后血栓并未消失,但变得更小。结论:静脉曲张的发生率尽管有预防性抗凝治疗,但短期内颈内静脉导管插入引起的血栓形成仍很高。这一发现重申了在临床上尽快拆除中央静脉导管的重要性。需要使用特定结果测试进行其他研究,以彻底评估该发现的临床重要性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号